Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions
SEC Form 4 Filing
Director Tariq Musa reports the vesting and conversion of restricted stock units into common stock.
Summary
- On April 15, 2024, Tariq Musa, a director of Guardant Health, Inc., reported a transaction involving the conversion of restricted stock units into common stock.
- 249 restricted stock units vested and were converted into 249 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Musa directly owns 3,247 shares of common stock and 8,745 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| March 6, 2023 | Date of grant for the restricted stock units vesting over a four-year period. |
| March 15, 2023 | One-year anniversary date for the initial vesting of 25% of the restricted stock units. |
| April 15, 2024 | Date of the reported transaction: conversion of restricted stock units into common stock. |
| April 16, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.